Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation. - Wikidata - awgldk - TriplyDB

Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation.

Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation.

http://www.wikidata.org/entity/Q34635121

about

Statin-induced lung injury: diagnostic clue and outcome The NLRP3 inflammasome and stroke Targeting the isoprenoid pathway to abrogate progression of pulmonary fibrosis Polymorphisms in inflammasome genes and risk of coal workers' pneumoconiosis in a Chinese population Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease Cellular mechanisms of tissue fibrosis. 8. Current and future drug targets in fibrosis: focus on Rho GTPase-regulated gene transcription.The mitochondrial cardiolipin remodeling enzyme lysocardiolipin acyltransferase is a novel target in pulmonary fibrosis.Lovastatin Inhibits Low Molecular Weight Hyaluronan Induced Chemokine Expression via LFA-1 and Decreases Bleomycin-Induced Pulmonary Fibrosis.Interstitial lung abnormalities in treatment-naïve advanced non-small-cell lung cancer patients are associated with shorter survival.Epithelial cell mitochondrial dysfunction and PINK1 are induced by transforming growth factor-beta1 in pulmonary fibrosis Carbon monoxide negatively regulates NLRP3 inflammasome activation in macrophages.Statin Use Is Associated with Reduced Mortality in Patients with Interstitial Lung Disease.Elevated cardiovascular risk among adults with obstructive and restrictive airway functioning in the United States: a cross-sectional study of the National Health and Nutrition Examination Survey from 2007-2010.The Metabolic Prospective and Redox Regulation of Macrophage Polarization.Occurrence of idiopathic pulmonary fibrosis during immunosuppressive treatment: a case report.Bisphosphonate Induces Osteonecrosis of the Jaw in Diabetic Mice via NLRP3/Caspase-1-Dependent IL-1β Mechanism.MUC5B promoter polymorphism and interstitial lung abnormalities.Comorbidities Among Persons With Incident Psychiatric Condition.Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis.Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.The inflammasome in lung diseases Inflammasomes in wound healing and fibrosis.Update in diffuse parenchymal lung disease 2012.Sterols and oxysterols in immune cell function.Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis.Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study.Cardiovascular and antacid treatment and mortality in oxygen-dependent pulmonary fibrosis: A population-based longitudinal study.Roles of the Mevalonate Pathway and Cholesterol Trafficking in Pulmonary Host Defense.Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES.Age-Dependent Susceptibility to Pulmonary Fibrosis Is Associated with NLRP3 Inflammasome Activation Biological insights from clinical trials and networks.Time to share: lessons from post hoc analyses of IPF trials.Effects of simvastatin on pulmonary fibrosis, pulmonary hypertension and exercise capacity in bleomycin-treated rats.Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine.NSFC spurs significant basic research progress of respiratory medicine in China.

P2860

Q26822368-22FCBEEF-48FD-4E8F-AEEB-1027578E94A7 Q27001659-D05A66BD-5676-4D34-85AF-FA4A902F4F95 Q28387228-6B993C5D-1A4B-4E74-A0DE-2F2BBDD2E8F0 Q28390069-B6FC5635-E246-4AB1-9682-C3A0911AB2EE Q28391348-84A6D0F6-0212-4980-BD07-A22B3FCF3D6B Q33840143-083596CC-2A44-4457-A797-7003D7BC544D Q33901590-210CA767-B0A7-47F4-9822-243633203FB1 Q34350784-925BF768-D0F5-4927-98FD-FFE984CA1B15 Q35418456-AE58C4D7-CD27-45C0-B5DD-918801D88B32 Q35580488-FBAFD3A5-47D2-4949-9E29-791C20979A65 Q35622507-E5C12969-926A-488D-941C-BDDB6BC9E749 Q35810049-A05D5877-8151-434D-96E3-F0BC5A9A857E Q36539136-3C4B882F-035F-43F2-9617-6C687B46C5FF Q36659528-A7D90804-CC61-4510-99B2-A65B30E1A2BE Q37076998-5584C8D9-FB42-44D7-AF46-12E7FCAD268F Q37087037-D8E48A52-A32A-4773-8502-960DB9C86A45 Q37105760-2FEA618F-872A-4861-AF44-7AB2821E9BC5 Q37519692-25EA3D70-35BB-4CC6-9A12-2D729CCB8249 Q37616955-1C60B14A-5888-468B-99F5-DE4822BC9F54 Q37734257-79F2EAC4-4DF9-4F86-A13B-73C8DCE97BFD Q38035820-8BA325B1-6AE8-41C9-833A-551A5FDD8C73 Q38047815-2CBE1E27-487D-4F19-82D5-171091390CCE Q38103298-DD76480E-1CF5-4864-A339-FCD219316192 Q38130108-63903FFC-8F02-4DFE-9027-DD5025A91692 Q38432028-CC90BB99-913E-45F3-812D-3EA54452CBD1 Q39675660-D39D9B62-8539-4ED2-989A-2833516C0E6F Q40835675-70725D79-159A-4856-A928-CF0086F52276 Q40835741-9F0DA9E1-2C44-4E79-BF56-B6F217A2D128 Q41109284-1E7C667A-8A8F-4ED5-90B6-40698948C6BA Q41884288-8092FA02-380B-4E31-A741-B0B0B093F454 Q42592590-8379A4F9-F597-483C-8E29-5F3E2350BC1D Q47800234-AAD503E6-9201-44CA-B2AB-DFE25BD28A94 Q48111085-390E5520-C71D-442B-9856-EF1736C234DE Q48235186-41C0BC5D-9E8D-4C5C-B34F-A81041D30166 Q51612693-14B99E0D-58E8-4B68-B67C-344568130A7D

P2860

Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation.

http://www.wikidata.org/entity/Q34635121

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation.

@ast

Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation.

@en

Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation.

@nl

type

label

Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation.

@ast

Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation.

@en

Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation.

@nl

prefLabel

Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation.

@ast

Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation.

@en

Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation.

@nl

P1433

Q34635121-58B11E47-5B7C-4D4C-BD8F-E33F9A1358D7

P1476

Q34635121-2C6784C2-8A90-45FA-9B50-7CCB66629892

P2093

Q34635121-00D6A91D-60A9-4472-8F4F-8717ECEB1F87

Q34635121-09109093-BFAE-4096-8F6F-597BCBC0210E

Q34635121-12603C9A-5E96-4B1E-AC11-F63FA25BD733

Q34635121-131EEECB-5F0B-4FF1-9BA6-BCDC871586F3

Q34635121-16CF5CC7-5540-4A82-A697-656D50544152

Q34635121-32A40FD0-0204-441D-A5D4-4799F92CD4AA

Q34635121-3C65AB17-A89C-4A0F-B1A9-99D9B0F92333

Q34635121-45B90109-661F-46F2-95CF-C95EAF43010C

Q34635121-4E3599D0-DDAE-4DCA-899E-203A2DFBCDD0

Q34635121-5AE3FFBC-899D-4BCF-B0B3-0F2EE124AD9D

P2860

Q34635121-016AB14C-67B4-4D88-B1B2-98D3EEB700F2

Q34635121-0D9C469E-4E28-4957-8408-FA8023AE3F12

Q34635121-16D372BB-FE6A-4E6E-9F04-EEE7F9A2FFC1

Q34635121-19AD8BD8-FB82-4CB4-AFB2-9F7AE08D6403

Q34635121-1B754CE2-2373-4A64-989D-901376B70ECB

Q34635121-300C06D8-5C48-4947-BFEE-9457881E8265

Q34635121-3390E7DC-46EE-4619-B67F-050D004B760C

Q34635121-410CCB01-78E1-4E32-9757-15EEA40F8C07

Q34635121-44B279DF-6FCF-4782-BEE0-7EE2372D08F1

Q34635121-460CE1E5-E753-4D7D-8C47-BFF2D5DBF730

P304

Q34635121-95133701-8288-4279-9CEC-352DD113EC43

P31

Q34635121-71FA8103-655E-4D96-85B8-37889DADA720

P356

Q34635121-09BCB2EF-A91A-4916-A1B0-4FCD4012959B

P407

Q34635121-11034F13-DE36-48CD-9D8A-849B4E210AB7

P433

Q34635121-F18F4CCA-7421-461B-83D1-EC5E11F6DC3F

P478

Q34635121-005FD6AC-9852-4B0D-9726-28EDB294A31D

P577

Q34635121-02F42B6E-2886-4B93-BC7F-B22CAB042024

P698

Q34635121-84A11148-E7C9-488D-B9E1-090111B5AA58

P921

Q34635121-B1F8E559-A574-4A05-BC15-186EC30C5E17

Q34635121-D5A8845E-0BBE-4D2F-8F11-8F70EA4CF37B

P932

Q34635121-5DD7634C-5EAC-47E0-97E3-F9B937DD5D31

P356

RCCM.201108-1574OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation.

@en

P2093

Alejandro A Diaz

http://www.w3.org/2001/XMLSchema#string

Augustine M K Choi

http://www.w3.org/2001/XMLSchema#string

Avignat S Patel

http://www.w3.org/2001/XMLSchema#string

Blanca E Himes

http://www.w3.org/2001/XMLSchema#string

COPDGene Investigators

http://www.w3.org/2001/XMLSchema#string

Carolyn E Come

http://www.w3.org/2001/XMLSchema#string

Danielle Morse

http://www.w3.org/2001/XMLSchema#string

David A Lynch

http://www.w3.org/2001/XMLSchema#string

Edwin K Silverman

http://www.w3.org/2001/XMLSchema#string

Fernando J Martinez

http://www.w3.org/2001/XMLSchema#string

P2860

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

The Nalp3 inflammasome is essential for the development of silicosis

Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica

A role for mitochondria in NLRP3 inflammasome activation

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Soci

Obesity and the risk of heart failure

Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

P304

547-556

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201108-1574OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

185

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22246178

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

P932

3297101

http://www.w3.org/2001/XMLSchema#string